SCHEMBL952545

SCHEMBL952545

CC=NN=CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10049422 1.00
SCHEMBL11965827 1.00
SCHEMBL19058631 0.78
SCHEMBL20380422 0.78
SCHEMBL361722 0.73
SCHEMBL20460733 0.73
SCHEMBL10292659 0.73
SCHEMBL8231904 0.73
SCHEMBL13367442 0.73
SCHEMBL22313690 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070149717-A1 Functionalized polymers BRIDGESTONE CORPORATION (JP) 2007-06-28 US claimed
US-11433136-B2 Polyacetal polymers, conjugates, particles and uses thereof THE GENERAL HOSPITAL CORPORATION (US) 2022-09-06 US disclosed
CN-109069470-B Use of specific benzodihydrofuran lignans for inhibiting breast cancer cell metastasis 杨宁荪 2022-07-29 CN disclosed
US-20210085508-A1 NASAL CONGESTION, OBSTRUCTION RELIEF, AND DRUG DELIVERY SANOSTEC CORP (US) 2021-03-25 US disclosed
EP-2019691-B1 POLYMERS FOR FUNCTIONAL PARTICLES MASSACHUSETTS INST TECHNOLOGY (US) 2020-08-12 EP disclosed
WO-2020133023-A1 AMORPHOUS CYPYRAFLUONE TRIETHANOLAMINE SALT, PREPARATION METHOD THEREFOR AND USE THEREOF 青岛清原化合物有限公司 2020-07-02 WO disclosed
US-10639186-B2 Nasal congestion, obstruction relief, and drug delivery SANOSTEC CORP. (US) 2020-05-05 US disclosed
CN-106715479-B Catalyst for polymerization of conjugated diene, conjugated diene polymer, modified conjugated diene polymer, polybutadiene, and composition containing same 宇部兴产株式会社 2019-07-23 CN disclosed
EP-2259803-B2 DEVICE FOR PROMOTION OF HEMOSTASIS AND/OR WOUND HEALING FERROSAN MEDICAL DEVICES AS (DK) 2019-03-13 EP disclosed
US-20180360978-A1 POLYACETAL POLYMERS, CONJUGATES, PARTICLES AND USES THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2018-12-20 US disclosed
US-5460821-A Molecular transdermal transport system BIO STRATEGIES, LP 1995-10-24 US disclosed
WO-1995000088-A1 MOLECULAR TRANSDERMAL TRANSPORT SYSTEM MASIZ JOHN J (US) 1995-01-05 WO disclosed
US-4791174-A VINYLAROMATIC/DIENE LIVING POLYMERS MODIFIED BY IMINE, HYDRAZONE OR AZINE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 1988-12-13 US disclosed
US-4775633-A TREATMENT WITH ALDEHYDE OR KETONE TO FORM AZINES OR HYDRAZONS; PYROLYSIS, OXIDATION THERMEDICS INC. (US) 1988-10-04 US disclosed
US-4574059-A PHOSGENATION OF DIAMINE FORMED FROM HYDROGENATION AND HYDROGENOLYSIS OF 1,2-DIAZA-1,5,9-CYCLODODECADIENE ATOCHEM (FR) 1986-03-04 US disclosed
US-4545802-A PYRAZOLINE COMPOUNDS AS NITRIFICATION INHIBITORS OF NITROGEN FERTILIZERS THE DOW CHEMICAL COMPANY (US) 1985-10-08 US disclosed
US-4440901-A CHAIN-LENGTHENED POLAMIDES FROM CARBOXY-TERMINATED POLYESTERS OR -ETHERS AND A CYCLOHEXYL DIISOCYANATE; COATINGS BAYER AKTIENGESELLSCHAFT (DE) 1984-04-03 US disclosed
US-4176135-A FROM UREA AND A HYDROZONE OR A KETAZINE OR ALDAZINE OTSUKA KAGAKU YAKUHIN KABUSHIKI KAISHA (JP) 1979-11-27 US disclosed
US-4100111-A 1,10-SUBSTITUTED 1,10-DIAMINODECANES AS CURING AGENTS, HYDROGENATION OF 3,12-SUBSTITUTED 1,2-DIAZO-1,5,9-CYCLODODECATRIENES CIBA-GEIGY CORPORATION (US) 1978-07-11 US disclosed
US-3939147-A Novel 1,2-diaza-1,5,9-cyclo dodecatrienes and 1,2-diaza-1-cyclododecenes CIBA-GEIGY CORPORATION (US) 1976-02-17 US disclosed